Episode 63: Dr. Craig Greven Discusses Surgical Retina, the ACCORD eye study, and more

Greven, Craig.jpg


Dr. Craig Greven, Chairman of the Department of Ophthalmology at Wake Forest University School of Medicine in Winston-Salem, NC, joins the show to discuss his approach to various surgical retina conditions, the ACCORD eye study, and advice for newly minted retina attendings.

You can find this episode and all prior episodes on our website (Retinapodcast.com).

######## Episode Outline by @Mike Venincasa ########

[0:48] Introduction

[1:17] How did you end up becoming an ophthalmologist, and then a retina specialist?

[2:16] Was retina something you knew that you were interested in from the beginning, given your interest in neuroscience?

[3:55] Can you describe some of your current surgical preferences?

[6:14] How do you approach retinal detachments surgically?

[7:55] Some retrospective data have shown that phakic patients who receive vitrectomy alone may have a lower primary reattachment rate than patients who are phakic and have a buckle. Dr. Greven tends to feel that the buckle is more effective in the phakic patient simply because you’re not able to remove as much gel.

[8:50] How do you approach giant retinal tears?

[10:32] Transitioning to your research… what is the ACCORD trial you are involved with?

[14:14] Why don’t we discuss these implications of fenofibrate with other specialties more often? (“Low-dose fenofibrate daily might limit the progression of retinopathy.”)

[16:35] Do you use anti-VEGF for PDR at this point?

[18:40] Some groups have showed a greater risk of ocular HTN in patients with repeated anti-VEGF injections. How do you keep this in mind with your patients?

[20:41] What advice do you have for newly-minted retina specialists, and what challenges will they encounter?

[23:01] One final question: how do you keep a balance between your parenthood and your career?

[24:35] Conclusion


You can also find us on:
iTunes Store: https://tinyurl.com/l52dekk
Google Play: https://tinyurl.com/kcrgjv2
Twitter: https://tinyurl.com/k6fd4lg
Join the Email List: http://eepurl.com/cMjmMD